ONWARD Medical N.V. ( Euronext : ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities today announces it has secured the required approvals to enable Veterans Affairs (VA) and other government agencies to immediately purchase the ARC-EX System through federal procurement systems. This milestone is the first major benefit resulting from the Company's partnership with Lovell Government Services, a Service-Disabled Veteran- Owned Small Business (SDVOSB).
"Adding the ARC-EX System to two major US federal government purchasing platforms is an important step toward making our therapy broadly available to US military Veterans living with spinal cord injury," said Dave Marver, CEO, ONWARD Medical. "The VA serves a significant percentage of Americans with spinal cord injury, and establishing these procurement channels soon after FDA authorization demonstrates our commitment to ensuring federal healthcare providers have rapid access to the latest technology."
The ARC-EX System is now available to US government clinics and other healthcare facilities through the Department of Veterans Affairs' Federal Supply Schedule National Acquisition Center (VA FSS NAC) and General Services Administration (GSA) Advantage Catalog. These web-based procurement platforms are used to manage contracts and purchases for medical equipment, supplies, pharmaceuticals and other healthcare-related products and services by VA medical centers and other authorized government providers. This comprehensive access ensures VA, Military Health System (MHS), Indian Health Service (IHS) facilities, and other US government agencies have rapid access to ONWARD's breakthrough technology for their clinics and healthcare facilities treating people with spinal cord injuries.
"We are proud to partner with ONWARD Medical to bring their breakthrough ARC-EX System to Veterans and others served by federal healthcare systems," said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. "This collaboration combines our federal distribution expertise with ONWARD's innovative technology to improve access to care for those who have served our country. Together, we're dedicated to helping people with spinal cord injury regain function and independence."
As ONWARD Medical’s US government contracting and logistics partner, Lovell will also collaborate with the Company to make the ARC-EX System available through the Defense Logistics Agency's Electronic Catalog (ECAT) later this year, further broadening and facilitating purchase of the system by government healthcare providers. The ARC-EX System delivers targeted, programmed stimulation of the spinal cord to restore upper extremity strength and function in people with SCI. This first-of-its-kind therapy represents a significant advancement in the treatment options available to Veterans and others living with SCI. It was authorized for commercial sale in the US by the FDA in December 2024.